PEGylated Peptide for Targeted Inhibition of Human Antigen R as a Novel Therapeutic Strategy for Psoriasis: A Proof-of-Concept Study.

Saved in:
Bibliographic Details
Title: PEGylated Peptide for Targeted Inhibition of Human Antigen R as a Novel Therapeutic Strategy for Psoriasis: A Proof-of-Concept Study.
Authors: Chen YF; Master Program in Biomedicine, National Taitung University, Taitung, Taiwan.; Department of Chemical Engineering, National Cheng Kung University, Tainan, Taiwan., Jiang YS; Department of Chemical Engineering, National Cheng Kung University, Tainan, Taiwan., Chen YC; Department of Internal Medicine, National Cheng Kung University Hospital, Tainan, Taiwan., Chang CH; Department of Chemical Engineering, National Cheng Kung University, Tainan, Taiwan., Jan JS; Department of Chemical Engineering, National Cheng Kung University, Tainan, Taiwan.
Source: Psoriasis (Auckland, N.Z.) [Psoriasis (Auckl)] 2025 Nov 29; Vol. 15, pp. 545-559. Date of Electronic Publication: 2025 Nov 29 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Dove Medical Press Country of Publication: New Zealand NLM ID: 101709086 Publication Model: eCollection Cited Medium: Internet ISSN: 2230-326X (Electronic) Linking ISSN: 2230326X NLM ISO Abbreviation: Psoriasis (Auckl) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2230-326X
DOI:10.2147/PTT.S563589